Uncategorized
Surgery should be considered for anti-VEGF non-responders
BASSANO DEL GRAPPA, Italy — When patients with age-related macular degeneration do not respond to anti-VEGF therapy, even after switching to a second drug, they should be promptly referred to a vitreoretinal surgeon to evaluate potential surgical options, according to one specialist. “Persisting with a pharmacological therapy that doesn’t work could rapidly lead to irreversible photoreceptor damage and hinder the possibility to successfully manage these patients surgically,” Ezio Cappello, MD, said at the Bassano Ophthalmology Meeting.